EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The First Evidence for the Role of ACVR2A Gene Fetal Genotype in Preeclampsia Susceptibility

Asal Honarpour, Ahmad Majd, Hossein Sadeghi iD, Sayedhamid Jamaldini, Maryam Rahimi, Paniz Kazemzadeh, Reza Mirfakhraie iD

Molecular Genetics & Genomic Medicine · 2025-02 · 13 (2)

DOI: 10.1002/mgg3.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 03.02.2025. Verfasst von Asal Honarpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Biology Science, North Tehran Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Pre-Eclampsia, Activin Receptors, Type II, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The activin A receptor type 2A gene ( ACVR2A ) plays an important role in normal gestation, particularly in decidualization, trophoblastic invasion, and placentation. Although several studies have investigated the association between ACVR2A maternal variants and preeclampsia (PE) susceptibility; however, controversial results were obtained. Moreover, in none of the previous studies, the role of ACVR2A fetal variants was explored. The aim of the present study was to investigate the role of ACVR2A rs1424954 and rs1424941 polymorphisms in PE susceptibility considering the impact of both fetal and maternal genotypes.

Methods

For genotyping of ACVR2A rs1424954 and rs1424941, we performed TP‐ARMS‐PCR on 600 samples, including 400 peripheral blood samples from preeclamptic and normal women and 200 umbilical cord blood samples from each group of pregnant women.

Results

Regarding rs1424954, only the fetal genotypes were associated with an increased risk of PE in both dominant and recessive inheritance models (OR = 2.88, 95% CI: 1.58–5.25, p = 0.0005; and OR = 2.43, 95% CI: 1.21–4.87, p = 0.012; respectively). For ACVR2A rs1424941variant, both maternal and fetal heterozygote genotypes were associated with PE susceptibility (OR = 1.57, 95% CI: 1.02–2.04, p = 0.04; and OR = 1.90, 95% CI: 1.02–3.54, p = 0.04; respectively).

Conclusion

The present study confirmed the role of fetal ACVR2A polymorphisms in PE pathogenesis for the first time. However, replicated studies in diverse ethnicities are necessary to confirm the role of fetal genotype on susceptibility to PE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaActivin Receptors, Type IIPolymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansFemalePregnancyAdultGenotype

Stichwörter der Autor:innen

ACVR2Afetal genotypepolymorphismpreeclampsia

Substanzen

Activin Receptors, Type IIactivin receptor type II-A

Autor:innen und Institutionen

  • Department of Genetics, Faculty of Biology Science, North Tehran Branch, Islamic Azad University, Tehran, Iran.
  • Department of Biology, Faculty of Biology Science, Islamic Azad University, Tehran, Iran.
  • Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Gynecology and Obstetrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Hossein Sadeghi, Reza Mirfakhraie

Förderung

  • Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences

Zitieren

APA

Honarpour, A., Majd, A., Sadeghi, H., Jamaldini, S., Rahimi, M., Kazemzadeh, P., & Mirfakhraie, R. (2025). The First Evidence for the Role of ACVR2A Gene Fetal Genotype in Preeclampsia Susceptibility. Molecular Genetics & Genomic Medicine, 13(2). https://doi.org/10.1002/mgg3.70069

Vancouver

Honarpour A, Majd A, Sadeghi H, Jamaldini S, Rahimi M, Kazemzadeh P, et al. The First Evidence for the Role of ACVR2A Gene Fetal Genotype in Preeclampsia Susceptibility. Molecular Genetics & Genomic Medicine. 2025;13(2). doi:10.1002/mgg3.70069

BibTeX
@article{Honarpour2025,
  author = {Honarpour, Asal and Majd, Ahmad and Sadeghi, Hossein and Jamaldini, Sayedhamid and Rahimi, Maryam and Kazemzadeh, Paniz and Mirfakhraie, Reza},
  title = {The First Evidence for the Role of ACVR2A Gene Fetal Genotype in Preeclampsia Susceptibility},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  volume = {13},
  number = {2},
  doi = {10.1002/mgg3.70069}
}
Kostenlos starten →